Marshall J.
Marshall J. Bonacquisti, Newark, DE US
Patent application number | Description | Published |
---|---|---|
20150186863 | ACCOUNT PURCHASE LIMITS FOR DEPENDENT USER - Embodiments of the prevent invention allow a primary user to create a dependent account in order to control and monitor the transactions made by a dependent user. The primary user can limit the transactions that the dependent user can make at a store or for products. The primary user can set transaction amount limits and transaction time limits on the transactions the dependent user can make. The primary user may also set allocation limits that limit the amount of an allowed transaction that can be applied to the dependent account. The difference between the allowed transaction amount and the allocation limit amount is paid for through the use of another account. The alternate account may be pre-determined, may be determined at the time of the transaction, or at a later point in time after the transaction has been completed between the dependent user and the merchant. | 07-02-2015 |
20150186886 | PURCHASE LIMITS WITH PRIMARY ACCOUNT HOLDER CONTROL - Embodiments of the prevent invention allow a primary user to create a dependent account in order to control and monitor the transactions made by a dependent user that is authorized to use the dependent account. The primary user can limit the transactions that the dependent user can make at a store or for products. The primary user can set transaction amount limits and transaction time limits on the transactions the dependent user can make at the blocked/approved stores or on the blocked/approved products. The primary user can set other limits, such as transaction type limits (e.g., in store purchase vs online purchase, or the like), location limits (e.g., radius location, zip code, state, region, or the like), or variance limits (e.g., particular transactions may be a percentage or dollar amount over the limits). | 07-02-2015 |
Marshall J. Nepras, Burlington, WI US
Patent application number | Description | Published |
---|---|---|
20100197560 | Fabric Conditioning Active Compositions - A fabric conditioning active composition comprising an esterquat mixture of quaternised mono- di- and tri-esters of alkanolamine in which the tri-esterquat content of the quaternised esterquat mixture is from 25 to 50% by weight of said esterquat mixture. Additionally, (i) when the triesterquat content is from 25 to 30% by weight of said esterquat mixture the free amine content of the composition is less than 0.5% by weight on the weight on said esterquat mixture, and (ii) when the tri-esterquat content is more than 30% by weight of said esterquat mixture the free amine content of the composition is less than 6% by weight based on the weight of said esterquat mixture. The composition may contain less than 1% by weight of free fatty acid based on said esterquat mixture. | 08-05-2010 |
20120309993 | CATALYST FOR ESTERAMINE PRODUCTION - Provided are methods for decreasing the reaction time between an alkanolamine such as triethanolamine and a fatty acid alkyl ester such as, a triglyceride, a vegetable oil, a methyl ester, an ethyl ester, etc., a fatty acid, or a mixture thereof The methods utilize a divalent zinc catalyst to facilitate and accelerate an esterification or transesterification reaction between the alkanolamine and the fatty acid, or fatty acid alkyl ester. | 12-06-2012 |
20130225859 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS - Esteramine compositions and their derivatives are disclosed. The esteramines comprise a reaction product of a metathesis-derived C | 08-29-2013 |
Marshall J. Rasmussen, Mesa, AZ US
Patent application number | Description | Published |
---|---|---|
20140088656 | THERAPY DELIVERY METHOD AND SYSTEM FOR IMPLANTABLE MEDICAL DEVICES - Recent advancements in power electronics technology have provided opportunities for enhancements to implantable medical device circuits. The enhancements have contributed to increasing circuit miniaturization and increased efficiency in the operation of the implantable medical devices. Stimulation therapy waveforms generated by the circuits include a stepped leading-edge that may be shaped having a varying slope and varying amplitudes associated with each of the segments of the slope. A charging circuit having a single primary transformer winding and a single secondary transformer winding that is coupled to a plurality of capacitors is utilized to generate the therapy stimulation waveforms. The stimulation waveform of the present disclosure may be dynamically shaped as a function of an individual patient's response. Such stimulation waveforms facilitate achieving lower capture thresholds which reduces the device's supply consumption thereby increasing longevity of the device and facilitate a reduction of tissue damage. | 03-27-2014 |
20140088659 | THERAPY DELIVERY METHOD AND SYSTEM FOR IMPLANTABLE MEDICAL DEVICES - The disclosure relates to an apparatus and method for inducing ventricular fibrillation in a patient to facilitate defibrillation threshold testing. The apparatus includes a plurality of output capacitors that are dynamically configurable in a selected stacking arrangement that facilitates delivery of energy for inducing the ventricular fibrillation. An output of the apparatus is coupled to patient electrodes and a threshold energy level delivered by the output capacitors is determined | 03-27-2014 |
20140277285 | SUBTHRESHOLD LEAD IMPEDANCE MEASUREMENT FOR SUBCUTANEOUS DEVICE - A subthreshold lead impedance technique is described for an implantable medical device. The lead impedance technique may be applicable to a subcutaneous implantable cardioversion defibrillator device and utilizes an output circuit of the device coupled between a first diode and a second diode to define a current path through two electrodes coupled to the output circuit. The second diode is further coupled to a switch to provide a current pathway from the first diode to circuit ground. A control circuit is coupled to the output circuit, the first diode, the second diode, and the switch to bias a leg of the output circuit in a conducting state while biasing the other legs of the output circuit in a non-conducting state. | 09-18-2014 |
20150134021 | THERAPY DELIVERY METHOD AND SYSTEM FOR IMPLANTABLE MEDICAL DEVICES - Recent advancements in power electronics technology have provided opportunities for enhancements to circuits of implantable medical devices. The enhancements have contributed to increasing circuit miniaturization and an increased efficiency in the operation of the implantable medical devices. The therapy delivery circuits and techniques of the disclosure facilitate generation of a therapy stimulation waveform that may be shaped based on the patient's physiological response to the stimulation waveform. The generated therapy stimulation waveforms include a stepped leading-edge that may be shaped having a varying slope and varying amplitudes associated with each of the segments of the slope. Unlike the truncated exponential waveform delivered by the conventional therapy delivery circuit which is based on the behavior of the output capacitors (i.e., i=C(dV/dt)), the stimulation waveform of the present disclosure may be dynamically shaped as a function of an individual patient's response. The dynamically shaped therapy stimulation waveforms facilitate achieving lower capture thresholds which reduces the device's supply consumption thereby increasing longevity of the device and facilitate a reduction of tissue damage. | 05-14-2015 |